Browse the evidence

The automated, online, behavioral obesity treatment program (Rx Weight Loss) produced a mean estimated weight loss of 3.60 kg at 3 months.

Practitioners can consider automated online programs as effective for initial weight loss.

At 12 months, weight regain was significantly less in the monthly and refresher maintenance groups compared to the newsletter control group.

Ongoing maintenance interventions are essential to prevent weight regain after initial weight loss.

The pragmatic implementation of the Rx Weight Loss program resulted in clinically significant weight loss over 2 years.

Clinicians can implement automated online obesity treatments for sustained weight management.

A 28-day carbohydrate-restricted diet resulted in a decrease in body fat by approximately 2.4 kg.

Implementing a carbohydrate-restricted diet may help firefighters reduce body fat.

Performance in a 2.41-km run and pull-up test improved after the carbohydrate-restricted diet.

Firefighters may enhance their physical performance through a carbohydrate-restricted diet.

GLP-1s reduce body weight by 5% to 18% in trials.

Clinicians can expect significant weight loss in patients using GLP-1s.

The position statement reviews current knowledge and gaps regarding exercise and management issues for athletes with diabetes.

This statement can guide healthcare professionals in addressing exercise-related concerns for diabetic athletes.

Ten days of low energy availability (LEA) resulted in impaired performance in trained females, with reductions in muscle glycogen content and physical performance parameters.

Athletes should be cautious about using low energy availability strategies as they may impair performance.

Maximizing exercise-induced muscle hypertrophy requires an energy surplus.

Practitioners should ensure that athletes are in a caloric surplus to optimize muscle growth.

Gains in muscle mass can be achieved under hypocaloric conditions.

While muscle gain is possible in a deficit, a surplus is recommended for optimal results.

A 2-month very low energy diet (VLED) resulted in a reduction of waist circumference by 10.6 cm and total weight loss of 12.9 kg in obese patients with obstructive sleep apnea (OSA).

Implementing a VLED can lead to significant weight loss and waist circumference reduction in obese patients with OSA.

A structured weight loss maintenance program incorporating commonly used diets was feasible, tolerable, and efficacious for 10 months after rapid weight loss.

Practitioners can consider structured maintenance diets to support weight loss in OSA patients.

The study provides a comprehensive evaluation of the effects of semaglutide for obesity or overweight.

Clinicians can refer to this study for a balanced view of semaglutide's effects.

HU6 treatment for 19 weeks significantly decreased body weight by -2.86 kg compared to placebo (P = .003).

HU6 may be an effective treatment option for weight loss in patients with obesity-related HFpEF.

HU6 treatment significantly decreased total fat mass by -2.96 kg compared to placebo (P < .001).

HU6 may help reduce fat mass in patients with obesity-related HFpEF.

Recommendations for dietary guidelines should be expressed in terms of foods and not macronutrients.

Practitioners should focus on food-based dietary recommendations rather than macronutrient ratios.

Gastric band (GB) surgery achieved a median weight loss of 9.8% at 10 years compared to 5.6% in the medical group (median difference 4.2%; p = .008).

GB surgery may be a more effective option for weight loss in overweight individuals with type 2 diabetes compared to medical care.

The review proposes practical ways to implement intermittent energy restriction methodologies.

Practitioners can utilize the proposed methods for better implementation of IER.

Consumers currently taking a GLP-1 consume significantly fewer calories than the other groups surveyed, with calorie reduction while taking a GLP-1 for weight loss estimated to be around 720 to 990 calories.

Practitioners should consider that GLP-1 users may have lower caloric intake, which could influence dietary recommendations.

GLP-1 users most likely reduce consumption of processed foods, sugar-sweetened beverages, refined grains, and beef.

Dietitians may need to adjust food recommendations for patients using GLP-1 based on their reduced consumption of certain food types.

Individuals in the Persistent+GLP-1 naive cohort achieved a mean weight reduction of 12.9% at 6-months post-index.

Practitioners can expect significant weight loss in eligible patients using tirzepatide over a 6-month period.

Moderate and balanced consumption of macronutrients associated with calorie restriction is recommended for patients with metabolic syndrome.

Practitioners should recommend a balanced diet with calorie restriction for patients with metabolic syndrome.

Participants in the Kaupapa Māori fitness and exercise programme lost an estimated 5.2 kg per participant per 100 days.

Fitness programmes designed with cultural values can effectively support weight loss in Māori populations.

Moderate and balanced consumption of macronutrients associated with calorie restriction is recommended for metabolic syndrome.

Practitioners should recommend a balanced diet with calorie restriction for patients with metabolic syndrome.